SCHEDULE 13G/A: ORI Healthcare Entities and Ms. Song Disclose Passive Stakes in CG Oncology, Inc.

A group of entities including ORI Healthcare Fund, L.P., ORI Healthcare Fund II, L.P., and their affiliates, along with Ms. Hong Fang Song, have filed an amended Schedule 13G disclosing their passive beneficial ownership in CG Oncology, Inc.

Summary

• This document is an Amendment No. 1 to Schedule 13G filed by multiple reporting persons regarding their beneficial ownership of common stock in CG Oncology, Inc.
• The filing discloses beneficial ownership by a group of related entities and an individual, Ms. Hong Fang Song, with the ownership percentages calculated based on 76,037,858 shares of Common Stock outstanding as of December 16, 2024.
• Ms. Hong Fang Song is reported as the largest beneficial owner within this group, holding an aggregate of 4,211,341 shares, which represents approximately 5.5% of the outstanding common stock.
• Ms. Song's beneficial ownership includes 613,928 shares held directly by her and 6,500 shares underlying options exercisable by December 31, 2024, or within 60 days thereafter, in addition to shares beneficially owned through Healthcare Seed Limited.
• Healthcare Seed Limited beneficially owns 3,590,913 shares, representing approximately 4.7% of the outstanding common stock, which includes shares held by Unique Diamond Investments Limited (0.8%) and Charming Jade Limited (4.0%).
• The filing indicates a passive investment intent, as it is filed under Rule 13d-1(b).

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership, indicating a neutral sentiment. It does not contain positive or negative operational or financial news.

Positives

• The disclosure of a significant, albeit passive, stake by institutional investors (ORI Healthcare Funds) and a key individual (Ms. Song) could be interpreted as a signal of confidence in CG Oncology, Inc.

Future Outlook

NA

Industry Context

This Schedule 13G filing indicates a passive investment by a group of healthcare-focused funds and an individual in CG Oncology, Inc., a company likely operating in the biotechnology or pharmaceutical sector given its name. Such filings are standard disclosures for significant ownership stakes and do not inherently reflect broader industry trends beyond the general interest of healthcare investors in the sector.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant ownership stakes, which can influence market perception and liquidity.

Key Dates

Keywords

CG Oncology Inc., SEC filing, Schedule 13G, beneficial ownership, common stock, ORI Healthcare Fund, Hong Fang Song, passive investment, institutional ownership, biotechnology, pharmaceuticals